Expression of hypoxia-inducible factor 1alpha in epithelial ovarian tumors: its impact on prognosis and on response to chemotherapy.

P. Birner, Martin Schindl, Andreas Obermair, +2

PubMed

Evaluation of the United States Food and Drug Administration-approved scoring and test system of HER-2 protein expression in breast cancer.

P. Birner, Georg Oberhuber, Josefine Stani, +8

PubMed

Overexpression of Id-1 protein is a marker for unfavorable prognosis in early-stage cervical cancer.

Monika Schindl, Georg Oberhuber, Andreas Obermair, +3

PubMed

PathologyCancer BiologyTumor BiologyDifferentiation/dna BindingCancer-associated Virus +15

Diagnosing Colitis: a Prospective Study on Essential Parameters for Reaching a Diagnosis

Clemens Dejaco, C. Oesterreicher, Sieglinde Angelberger, +5

Endoscopy

Relation between depression and anxiety in dystonic patients: implications for clinical management

E. Moraru, Peter Schnider, A. Wimmer, +4

Depression and Anxiety

Psychological Co-morbiditiesPsychiatric DisordersMental HealthPsychologyMental Disorders +17

Selective immunohistochemical staining of blood and lymphatic vessels reveals independent prognostic influence of blood and lymphatic vessel invasion in early-stage cervical cancer.

P. Birner, Andreas Obermair, Monika Schindl, +3

PubMed

ImmunologyPathologyCytopathologyTumor BiologyOncology +17

Marked increase of neuronal prion protein immunoreactivity in Alzheimer's disease and human prion diseases

Till Voigtländer, Stefan Klöppel, P. Birner, +6

Acta Neuropathologica

Marked IncreaseAlzheimer's DiseaseCreutzfeldt-jakob DiseaseDementiaHuman Prion Diseases +8

The expression of bone morphogenetic proteins in osteosarcoma and its relevance as a prognostic parameter

Irene Sulzbacher, P. Birner, Klemens Trieb, +2

Journal of Clinical Pathology

Cathepsin D in ovarian cancer: prognostic value and correlation with p53 expression and microvessel density

A Lösch, Monika Schindl, Petra Kohlberger, +4

Gynecologic Oncology

Cathepsin DMedicineP53 ExpressionPathologyGynecology +7

Combination of isocitrate dehydrogenase 1 (IDH1) mutation and podoplanin expression in brain tumors identifies patients at high or low risk of venous thromboembolism

Pegah Mir Seyed Nazari, Julia Riedl, Matthias Preusser, +8

Journal of Thrombosis and Haemostasis